FI97807B - Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat - Google Patents

Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat

Info

Publication number
FI97807B
FI97807B FI912315A FI912315A FI97807B FI 97807 B FI97807 B FI 97807B FI 912315 A FI912315 A FI 912315A FI 912315 A FI912315 A FI 912315A FI 97807 B FI97807 B FI 97807B
Authority
FI
Finland
Prior art keywords
furo
preparing
racemic form
pyridine derivative
pyridine
Prior art date
Application number
FI912315A
Other languages
English (en)
Finnish (fi)
Other versions
FI97807C (sv
FI912315A0 (sv
FI912315A (sv
Inventor
Charles R Eck
Paul C Ahrens
Rae Marie Saltzstein
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of FI912315A0 publication Critical patent/FI912315A0/sv
Publication of FI912315A publication Critical patent/FI912315A/sv
Application granted granted Critical
Publication of FI97807B publication Critical patent/FI97807B/sv
Publication of FI97807C publication Critical patent/FI97807C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI912315A 1990-05-14 1991-05-13 Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat FI97807C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof
US52323890 1990-05-14

Publications (4)

Publication Number Publication Date
FI912315A0 FI912315A0 (sv) 1991-05-13
FI912315A FI912315A (sv) 1991-11-15
FI97807B true FI97807B (sv) 1996-11-15
FI97807C FI97807C (sv) 1997-02-25

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912315A FI97807C (sv) 1990-05-14 1991-05-13 Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat

Country Status (32)

Country Link
US (1) US5130252A (sv)
JP (1) JPH05117277A (sv)
KR (1) KR910020015A (sv)
AR (1) AR247762A1 (sv)
AT (1) AT400445B (sv)
AU (1) AU642368B2 (sv)
BE (1) BE1007016A3 (sv)
CA (1) CA2042421C (sv)
CH (1) CH682488A5 (sv)
DE (1) DE4115681C2 (sv)
DK (1) DK88991A (sv)
DZ (1) DZ1499A1 (sv)
ES (1) ES2033574B1 (sv)
FI (1) FI97807C (sv)
FR (1) FR2661919B1 (sv)
GB (1) GB2244056B (sv)
GR (1) GR1001593B (sv)
HK (1) HK131993A (sv)
IE (1) IE65891B1 (sv)
IT (1) IT1248743B (sv)
LU (1) LU87935A1 (sv)
MA (1) MA22154A1 (sv)
MY (1) MY107567A (sv)
NL (1) NL194615C (sv)
NO (1) NO180308C (sv)
NZ (1) NZ238009A (sv)
OA (1) OA09352A (sv)
PT (1) PT97657B (sv)
SE (1) SE510808C2 (sv)
TN (1) TNSN91035A1 (sv)
TW (1) TW226998B (sv)
ZA (1) ZA913461B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
WO2005009446A1 (en) * 2003-07-17 2005-02-03 Cotherix, Inc. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US7375112B2 (en) * 2005-01-05 2008-05-20 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
CA2674367A1 (en) * 2007-01-03 2008-07-17 Glenn V. Cornett Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
EP2498605B1 (en) * 2009-10-29 2014-08-27 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (sv) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
DE3378834D1 (en) * 1982-08-13 1989-02-09 Kanegafuchi Chemical Ind Process for production of optically active oxazolidinone derivative
IN160104B (sv) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
ITMI911255A1 (it) 1992-11-08
SE510808C2 (sv) 1999-06-28
ES2033574A1 (es) 1993-03-16
GB9109810D0 (en) 1991-06-26
MY107567A (en) 1996-04-30
FI97807C (sv) 1997-02-25
FR2661919B1 (fr) 1994-12-30
ITMI911255A0 (it) 1991-05-08
NO180308B (no) 1996-12-16
FI912315A0 (sv) 1991-05-13
GB2244056A (en) 1991-11-20
KR910020015A (ko) 1991-12-19
JPH05117277A (ja) 1993-05-14
US5130252A (en) 1992-07-14
NZ238009A (en) 1992-11-25
ES2033574B1 (es) 1994-02-01
CA2042421A1 (en) 1991-11-15
ZA913461B (en) 1992-02-26
NL9100749A (nl) 1991-12-02
DK88991D0 (da) 1991-05-13
FI912315A (sv) 1991-11-15
MA22154A1 (fr) 1991-12-31
ATA98291A (de) 1995-05-15
PT97657A (pt) 1992-02-28
DZ1499A1 (fr) 2004-09-13
LU87935A1 (fr) 1992-03-03
FR2661919A1 (fr) 1991-11-15
DE4115681A1 (de) 1991-11-21
GR1001593B (el) 1993-03-31
BE1007016A3 (fr) 1995-02-21
CH682488A5 (fr) 1993-09-30
TW226998B (sv) 1994-07-21
DE4115681C2 (de) 2003-10-30
SE9101431L (sv) 1991-11-15
AU7620091A (en) 1991-11-14
AU642368B2 (en) 1993-10-14
GR910100180A (en) 1992-07-30
PT97657B (pt) 1998-09-30
IE65891B1 (en) 1995-11-29
NO180308C (no) 1997-03-26
DK88991A (da) 1991-11-15
HK131993A (en) 1993-12-10
SE9101431D0 (sv) 1991-05-13
IE911628A1 (en) 1991-11-20
NL194615C (nl) 2002-09-03
GB2244056B (en) 1993-08-11
IT1248743B (it) 1995-01-26
NL194615B (nl) 2002-05-01
OA09352A (fr) 1992-09-15
TNSN91035A1 (fr) 1992-10-25
NO911852L (no) 1991-11-15
CA2042421C (en) 2000-08-22
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
NO911852D0 (no) 1991-05-13

Similar Documents

Publication Publication Date Title
FI96029B (sv) Analogiförfarande för framställning av ett som läkemedel användbart pyridinderivat
FI98192B (sv) Förfarande för framställning av en näringskomposition
FI890282A (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI895741A0 (sv) Förfarande för att dekorera ett ämne, användning av förfarandet och medelst förfarandet framställda produkter
EG18150A (en) Process for preparing furo-(3,4-c)-pyridine derivatives
FI97807B (sv) Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat
FI104171B (sv) Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar
PT81669A (en) Process for preparing 13beta-milbemycin derivatives useful as pesticides
FI98459B (sv) Förfarande för framställning av terapeutiskt användbara 5-etano-2,3,4,5-1H-2-bentsazsepin
FI913554A (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
FI905445A0 (sv) Förfarande för framställning av terapeutiskt användbara 4-amidinokroman- och 4-amidinopyrano/3,2-c/pyridinderivat
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
FI881060A0 (sv) Förfarande för framställning av en ostsmakande smakämnesblandning
FI891111A0 (sv) Förfarande för framställning av 1,4-dihydropyridinderivat
FI892144A (sv) Förfarande för framställning av 5-C-hydroximetylaldohexosbaserade föreningar
FI893964A (sv) Förfarande för framställning av en instant mousseblandning
FI912705A0 (sv) Förfarande för framställning av dragkedjor
FI905226A0 (sv) Förbättrat förfarande för framställning av användbara piperidinderivat
HUT38943A (en) Process for preparing n up 7 substituted c-mithomycine derivatives
NO174150C (no) Fremgangsmåte for fremstilling av furo-(3,4-c)pyridin-derivater i ikke-racemisk form
FI912247A (sv) Förfarande för framställning av terapeutiskt användbara pyrrolo/2,3-b/indolketonderivat
FI885033A0 (sv) Förfarande för framställning av 1,5-bensotiazepinderivat
PT86829A (pt) Process for preparing thienothiopyran derivatives
FI960490A0 (sv) Förfarande för framställning av sackarinderivat
NO934268D0 (no) Fremgangsm}te for fremstilling av 3-substituerte-2-oksindol-derivater

Legal Events

Date Code Title Description
BB Publication of examined application